找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Immunology: Innovative Approaches to Therapy; Ronald B. Herberman (Director) Book 1986 Martinus Nijhoff Publishers, Boston 1986 Ant

[復(fù)制鏈接]
查看: 37184|回復(fù): 38
樓主
發(fā)表于 2025-3-21 19:10:06 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Cancer Immunology: Innovative Approaches to Therapy
編輯Ronald B. Herberman (Director)
視頻videohttp://file.papertrans.cn/222/221133/221133.mp4
叢書名稱Cancer Treatment and Research
圖書封面Titlebook: Cancer Immunology: Innovative Approaches to Therapy;  Ronald B. Herberman (Director) Book 1986 Martinus Nijhoff Publishers, Boston 1986 Ant
描述This volume is the second in the ‘Cancer Treatment and Research‘ series focussing on basic and clinical tumor immunology. It has a rather different focus or emphasis from that of the first volume, published two years ago. That work (Basic and Clinical Tumor Immunology, R.B. Herberman, ed., Martinus Nijhoff Publishers, 1983) devoted considerable attention to up- dated summaries in various areas of classical tumor immunology: specific antitumor immunity, the immunologic competence of cancer patietns, char- acterization of human tumor-associated antigens, the ability to propagate specifically immune T cells in culture in the presence of interleukin 2, and the use of such cells for adoptive immunotherapy of established tumors. of evidence concerning the immune However, it also reviewed the status surveillance hypothesis and pointed out the need to consider non-T cell mediated mechanisms of host resistance. In particular, one chapter sum- marized information on the role of macrophages in host resistance against tumors. The present volume continues to emphasize one of the major themes of the first volume, innovative approaches to the therapy of cancer. It involves contributions from lead
出版日期Book 1986
關(guān)鍵詞Antigen; DNA; cancer treatment; cell; cytotoxicity; immunobiology; immunotherapy; leukemia; lymphoma; macroph
版次1
doihttps://doi.org/10.1007/978-1-4613-2629-8
isbn_softcover978-1-4612-9643-0
isbn_ebook978-1-4613-2629-8Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightMartinus Nijhoff Publishers, Boston 1986
The information of publication is updating

書目名稱Cancer Immunology: Innovative Approaches to Therapy影響因子(影響力)




書目名稱Cancer Immunology: Innovative Approaches to Therapy影響因子(影響力)學(xué)科排名




書目名稱Cancer Immunology: Innovative Approaches to Therapy網(wǎng)絡(luò)公開度




書目名稱Cancer Immunology: Innovative Approaches to Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Immunology: Innovative Approaches to Therapy被引頻次




書目名稱Cancer Immunology: Innovative Approaches to Therapy被引頻次學(xué)科排名




書目名稱Cancer Immunology: Innovative Approaches to Therapy年度引用




書目名稱Cancer Immunology: Innovative Approaches to Therapy年度引用學(xué)科排名




書目名稱Cancer Immunology: Innovative Approaches to Therapy讀者反饋




書目名稱Cancer Immunology: Innovative Approaches to Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:35:11 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:17:37 | 只看該作者
地板
發(fā)表于 2025-3-22 06:32:06 | 只看該作者
Monoclonal Antibody Therapy of Cancer: Preclinical Models and Investigations in Humans,ell extracts, these monoclonal antibodies are mouse immunoglobulins. It is possible that the mouse will recognize antigenic determinants on the human tumor cell not well recognized by the patient’s own immune system.
5#
發(fā)表于 2025-3-22 10:34:32 | 只看該作者
0927-3042 fferent focus or emphasis from that of the first volume, published two years ago. That work (Basic and Clinical Tumor Immunology, R.B. Herberman, ed., Martinus Nijhoff Publishers, 1983) devoted considerable attention to up- dated summaries in various areas of classical tumor immunology: specific ant
6#
發(fā)表于 2025-3-22 15:37:23 | 只看該作者
https://doi.org/10.1007/978-1-349-24977-0tent and successful immunotherapy of human cancer remains an elusive goal [3]. Understanding the complex mechanisms regulating macrophage-mediated tumor cell destruction may ultimately lead to a rational basis for immunomodulation and, hence, successful immunologically based therapy of neoplastic diseases.
7#
發(fā)表于 2025-3-22 18:04:08 | 只看該作者
8#
發(fā)表于 2025-3-23 00:47:45 | 只看該作者
Book 1986cus or emphasis from that of the first volume, published two years ago. That work (Basic and Clinical Tumor Immunology, R.B. Herberman, ed., Martinus Nijhoff Publishers, 1983) devoted considerable attention to up- dated summaries in various areas of classical tumor immunology: specific antitumor imm
9#
發(fā)表于 2025-3-23 04:25:21 | 只看該作者
10#
發(fā)表于 2025-3-23 05:49:18 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 07:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
沙雅县| 沛县| 碌曲县| 灌阳县| 儋州市| 安陆市| 望谟县| 尼玛县| 静宁县| 乃东县| 肥城市| 宜昌市| 阿城市| 大理市| 中山市| 双牌县| 烟台市| 黄浦区| 达孜县| 济宁市| 昌黎县| 内黄县| 太湖县| 西乡县| 新郑市| 新竹县| 太康县| 灵川县| 册亨县| 蓝田县| 通道| 苍山县| 云阳县| 平泉县| 崇义县| 贞丰县| 株洲县| 莆田市| 廉江市| 威海市| 五台县|